These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34348812)

  • 1. Osteoclastic activity in chronic otitis media with cholesteatoma-related bone destruction.
    Özgür A; Yemiş T; Başbulut E; Turgut NF; Özdemir D; Akgül G; Mehel DM; Çelebi M
    J Laryngol Otol; 2021 Oct; 135(10):879-882. PubMed ID: 34348812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular control of bone resorption in chronic otitis media with cholesteatoma].
    Kuczkowski J; Kobierska-Gulida G; Izycka-Swieszewska E; Potocka M; Mikaszewski B; Sierszeń W
    Otolaryngol Pol; 2010; 64(4):219-24. PubMed ID: 20873097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma.
    Yetiser S; Satar B; Aydin N
    Otol Neurotol; 2002 Sep; 23(5):647-52. PubMed ID: 12218613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone resorption in chronic otitis media: the role of the osteoclast.
    Jung JY; Chole RA
    ORL J Otorhinolaryngol Relat Spec; 2002; 64(2):95-107. PubMed ID: 12021500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoclasts in chronic otitis media, cholesteatoma, and otosclerosis.
    Chole RA
    Ann Otol Rhinol Laryngol; 1988; 97(6 Pt 1):661-6. PubMed ID: 3202569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone resorption in human cholesteatoma: morphological study with scanning electron microscopy.
    Uno Y; Saito R
    Ann Otol Rhinol Laryngol; 1995 Jun; 104(6):463-8. PubMed ID: 7771720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoclasts are not activated in middle ear cholesteatoma.
    Koizumi H; Suzuki H; Ikezaki S; Ohbuchi T; Hashida K; Sakai A
    J Bone Miner Metab; 2016 Mar; 34(2):193-200. PubMed ID: 25796629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
    Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
    Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and diagnostic observations of a complicated course of chronic otitis media, cholesteatoma in children].
    Sambulov VI; Stepanova EA
    Vestn Otorinolaringol; 2019; 84(4):51-54. PubMed ID: 31579059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone Damage in Chronic Otitis Media.
    Kuczkowski J; Brzoznowski W; Nowicki T
    Ear Nose Throat J; 2022 Aug; 101(7):428-429. PubMed ID: 33090898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
    Sanković-Babić S; Sofronić-Milosavljević Lj
    Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone destruction mechanisms in chronic otitis media with cholesteatoma: specific production by cholesteatoma tissue in culture of bone-resorbing activity attributable to interleukin-1 alpha.
    Kurihara A; Toshima M; Yuasa R; Takasaka T
    Ann Otol Rhinol Laryngol; 1991 Dec; 100(12):989-98. PubMed ID: 1746847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is reuse of autologous ear ossicles in cholesteatoma or chronic suppurative otitis media justified?].
    Peng JC; Hoppe F
    Laryngorhinootologie; 1994 Jul; 73(7):375-80. PubMed ID: 7916783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biochemical studies of bone destruction in cholesteatoma.
    Amar MS; Wishahi HF; Zakhary MM
    J Laryngol Otol; 1996 Jun; 110(6):534-9. PubMed ID: 8763371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of a pathological process in the destroyed tympanic part of the facial canal in chronic otitis media with cholesteatoma.
    Djerić D; Savić D
    Rev Laryngol Otol Rhinol (Bord); 1989; 110(5):449-51. PubMed ID: 2633247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum sclerostın levels ın chronıc otıtıs medıa wıth and wıthout cholesteatoma.
    Karali E; Yis OM
    Rev Assoc Med Bras (1992); 2020 Jul; 66(7):966-972. PubMed ID: 32844952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of tumor necrosis factor-α, interleukin-1α, interleukin-6 and interleukin-10 in chronic otitis media with bone osteolysis.
    Kuczkowski J; Sakowicz-Burkiewicz M; Iżycka-Świeszewska E; Mikaszewski B; Pawełczyk T
    ORL J Otorhinolaryngol Relat Spec; 2011; 73(2):93-9. PubMed ID: 21311206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utilization of Chronic Otitis Media Questionnaire-12 in chronic otitis media with or without cholesteatoma.
    Demir B; Sahin A; Binnetoglu A; Batman C
    Eur Arch Otorhinolaryngol; 2020 Nov; 277(11):3037-3043. PubMed ID: 32424496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
    Halleen JM; Tiitinen SL; Ylipahkala H; Fagerlund KM; Väänänen HK
    Clin Lab; 2006; 52(9-10):499-509. PubMed ID: 17078477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsin L activity and its inhibitor in human otitis media.
    Kusunoki T; Nishida S; Murata K; Kobashi K; Nakatani H; Hiwasa T; Tomura T
    J Otolaryngol; 2001 Jun; 30(3):157-61. PubMed ID: 11771045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.